Clinical Research Directory
Browse clinical research sites, groups, and studies.
Transcutaneous Pulsed Radiofrequency for the Treatment of Diabetic Peripheral Neuropathy Pain
Sponsor: Algiamed Technologies USA, Inc.
Summary
The purpose of this study is to determine if a non-invasive, electrical pulsed radio frequency (PRF) device can relieve pain and improve function in patients suffering from diabetic nerve pain in their feet, known as pedal diabetic peripheral neuropathy. Patients with this condition often experience severe pain, burning sensations, numbness, and tingling. Current medications for diabetic nerve pain often have unwanted side effects or do not provide sufficient relief. In this single-blind, randomized trial, participants are assigned to receive either an active PRF treatment or a placebo (sham) treatment. Both treatments involve placing the device safely behind the knee (targeting the sciatic nerve) for 10 minutes, once a week for 3 weeks. The main question this study aims to answer is whether the active PRF treatment reduces nerve pain and symptoms significantly more than the placebo, measured by standard symptom questionnaires over a 6-month period.
Official title: Can a Non-interventional Pulsed Radiofrequency Device Relieve Pain and Improve Function in Patients With Diabetic Neuropathy That Are Refractory to Medication? A Single Blind Randomized Placebo-controlled Trial
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
92
Start Date
2016-12
Completion Date
2019-08
Last Updated
2026-07-24
Healthy Volunteers
No
Conditions
Interventions
NMS 460 Pulsed Radio Frequency Device
Active transcutaneous electrical pulsed radio frequency stimulation. The device is applied bilaterally at the sciatic nerve in the popliteal fossa for 10 minutes, once weekly for 3 consecutive weeks.
Placebo Device
A sham device designed to look and operate like the active device but delivering no therapeutic current. It is applied bilaterally at the sciatic nerve in the popliteal fossa for 10 minutes, once weekly for 3 consecutive weeks to mimic the active treatment.
Locations (5)
Centre for Diabetes and Endocrinology (CDE), Houghton
Johannesburg, Gauteng, South Africa
Clinical Sites - West Johannesburg
Johannesburg, Gauteng, South Africa
Diabetic Clinic at the Charlotte Maxeke Hospital
Johannesburg, Gauteng, South Africa
Clinical Sites - Krugersdorp
Krugersdorp, Gauteng, South Africa
CDE / Clinical Sites - Pretoria
Pretoria, Gauteng, South Africa